EUCTR2008-000380-42-IT进行中（未招募）不适用
Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis - ND
ISTITUTO NEUROLOGICO CARLO BESTA0 个研究点开始时间: 2009年1月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •GBM of new diagnosis (histology). Age between 18 and 70 years. Karnofski Performance Status #8805; 70. Normal bone marrow, liver and kidney activity. No signs of active infection. Life expectancy > 12 weeks. Written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior radiotherapy Pregnancy
研究者
相似试验
已完成
不适用
Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Phase II StudyHead and neck squamous cell carcinoma at stage III and IVJPRN-C000000273Department of Otolaryngology, Osaka University School of Medicine160
已完成
2 期
Treatment outcome in head and neck cancer patients receiving carboplatin plus capecitabine based versus high dose cisplatin based chemoradiotherapy.CTRI/2020/11/029290Govt Kilpauk Medical College81
已完成
1 期
A phase I study of chemoradiotherapy (cisplatin and vinorelbine) with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung canceron-small-cell lung cancerJPRN-UMIN000003769Osaka Lung Cancer Study Group12
招募中
2 期
Induction chemoradiotherapy with cisplatin plus vinorelbine and irradiation, followed by surgery in cT1-3N2M0, stage IIIA non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000005416Kyoto University Hospital35
招募中
2 期
DCF-RT for T4b ECLocally advanced esophageal cancerEsophageal cancerJPRN-jRCTs051190058Miyata Hiroshi20